Diabetes & Metabolism

ASN Policy Q&A on the Advancing American Kidney Health initiative: Part 2

In order to double the number of kidneys available for transplant by 2030, the Administration is looking to increase the utilization of available organs from both deceased and living donors in multiple ways including, but not limited to:...

Diabetes and Kidney Disease 2019: August Special Section

Capture_title_0.PNGDiabetes is the second most common cause of kidney failure in the United States. Diabetic Kidney Disease (DKD) encompasses structural and functional abnormalities involving the kidneys. Clinically, these changes result in hypertension, proteinuria, and progressive decline in kidney function, ultimately leading to ESKD. Diabetic kidney disease accounts for more than 40% of all ESKD In the United States.

Dr. Reshma Kewalramani named incoming president and CEO of Vertex Pharmaceuticals, former member ASN KHI Board of Directors

Announced July 25, Dr. Reshma Kewalramani will be promoted to president and CEO of Vertex Pharmaceuticals. She is currently the chief medical officer for the company and was previously a practicing nephrologist who earned her medical doctorate at Boston University and trained at Bigham & Women’s Hospital.

Dr. Kewalramani will be the first woman to run a large biotechnology firm. Vortex’s share price “rose 360% and its sales doubled to $3 billion annually” under the previous CEO, largely due the company’s pharmaceuticals used to treat cystic fibrosis.

Breaking: HHS announcing rollout of new kidney strategy July 10th

Wednesday, July 10, the Trump administration will announce a new Department of Health and Human Services-wide (HHS) Comprehensive Kidney Care strategy. ASN and other kidney care groups have been working and meeting with Administration officials, including Secretary Alex M. Azar, II, all year providing input and recommendations for inclusion of in the new strategy.

Interview: Dr. Michael Allon, Editor-in-Chief of the new ASN journal, Kidney360

Kidney News Online (KNO) recently spoke with Michael Allon, MD, the inaugural Editor-in-Chief for the newest journal from the American Society of Nephrology, Kidney360. As the open access, online only journal will begin accepting manuscripts in September 2019, KNO wanted to learn more...

Kana Miyata, MD - Ben J. Lipps Research Fellowship Award (2019)

Name: Kana Miyata, MD

Institution: CRCHUM, University of Montreal

Grant: Ben J. Lipps Research Fellowship Award (2019)

Project Title: Novel Role of Heterogeneous Nuclear Ribonucleoprotein F (hnRNP F) in Regulation of Sodium-Glucose Cotransporter 2 (Sglt2) Expression in Diabetes
 

How would you sum up your research in one sentence?

Q&As with KidneyCure Grant Recipients 2019

The following articles are brief Q&A sessions with KidneyCure (ASN Foundation) grant recipients. The sessions explore what research the individual is undertaking with the grant funds, their hopes for the research, career goals, and advice for others interested in applying for these grant funds.

National Kidney Foundation Building First-Ever Patient Registry for Chronic Kidney Disease

Announced this week, the NKF Patient Network “will create an interactive community of chronic kidney disease (CKD) patients that link patient-entered data on their health history, outcomes and preferences with clinical and laboratory data obtained from electronic health records. This unique combination of data collected will enable individualized educational resources, research, clinical care and health policy decisions to be centered on the patient.”

ASN announces the first Editor-In-Chief of Kidney360, a new online open access journal

The American Society of Nephrology (ASN) today announced the appointment of Michael Allon, MD, as the first Editor-in-Chief of Kidney360, ASN’s new online journal launching in January 2020.

Funding Bill for NIH, KidneyX Receives Committee Approval and Moves Closer to Finalization

On Wednesday, May 8, the House Appropriations Committee voted to send the House Labor, Health and Human Services, and Education (LHHS) appropriations bill to the House floor for consideration. The bill and accompanying committee report provides a total of $189.9 billion in funding, a nearly $12 billion increase over FY 19 enacted levels, and includes a number of priorities of the American Society of Nephrology (ASN).

Pages